CARA LOVELESS-FAULKNER: Open Payments
NPI 1285352823 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 66 payments from 23 companies in 2025. Trend: 2023 $1,547 · 2024 $1,250 · 2025 $1,286
Food & beverage: $1,286
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $196 |
| ABBVIE INC. | 16 | $176 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Novo Nordisk Inc | 5 | $82 |
| Amgen Inc. | 5 | $80 |
| Merck Sharp & Dohme LLC | 3 | $79 |
| Aimmune Therapeutics, Inc. | 2 | $59 |
| ViiV Healthcare Company | 2 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Astellas Pharma US Inc | 2 | $42 |
Products named: BREZTRI, QULIPTA, TRELEGY ELLIPTA, PIFELTRO, AIRSUPRA, ZENPEP, GEMTESA, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
